Introduction
Gene knockout is used to study the function of specific gene, detect its protein product, and link it to physiological or pathological processes. Knockout can be deliberately made using different molecular techniques some of which, like homologous recombination, are lengthy and expensive. RNA interference (RNAi) has appeared as a novel pathway to knockdown specific mRNAs, thus preventing translation of the respective protein from occurring.
RNAi is a natural process-used in many different organisms to regulate endogenous gene expression-in which non-translated, long, double-stranded RNA (dsRNA) led to a strong, long lasting and specific silencing of selected genes [1] . Further studies revealed that small dsRNA of 21-25 bp (small interfering RNA = siRNA) derived from endonuclease Dicer-mediated processing of long dsRNAs interact with a protein complex to form the RNA-induced silencing complex (RISC) [2, 3] This complex has nuclease activity and digests mRNA containing a base pair sequence identical to that in the siRNA. Thus, the siRNA serves as a target sequence that allows RISC to recognize specific mRNAs and to prevent their translation by cleaving them [4] . Another method to produce siRNA is based on the use of short hairpin RNAs (ShRNAs) that trigger RNAi [5, 6] . Short (60-75 bp long) DNA oligodesoxynucleotides that form hairpins are cloned into a plasmid under the control of the U6 or H1 promoter for RNA polymerase III. Transfection of such a plasmid promotes the expression of ShRNAs that induce RNAi. Nonreplicating recombinant viral vectors (adeno, adeno-associated and lentiviruses) are commonly used for ShRNA expression in primary neuronal cells. Lentiviruses may be particularly suited for long-term ShRNA and expression and gene silencing in vivo since the viral DNA gets incorporated in the host genome.
Commonly used lentiviral vector systems belong to the second or third generation, ensuring safe application, as these viruses are unable to self-replicate, since the spontaneous selfassembly is prevented by distributing the least necessary number of virus elements on three and four plasmids, respectively. Here, we describe the methods used in our laboratory to silencing SR in rat CGNs as a tool for identifying the role of this enzyme during apoptosis. 
Methods
ShRNA oligonucleotide design describes the process of identifying target sequences within a gene of interest and designing the corresponding oligonucleotides to generate the ShRNA. A number of algorithms may been utilized to predict effective siRNA sequences and design ShRNA (e.g., http://www.ambion. com/ or http://sfold.wadsworth.org/; http://eu.idtdna.com/ Scitools/Applications/shRNA etc). Here are general guidelines for ShRNA design based on the work of Tuschl et al. [8] and Elabishir et al. [9, 10] (see also: http://www.mpibpc.gwdg.de/ abteilungen/100/105/sirna.htmL).
1. Select a region of 19 nt within the gene to be silenced [in our case, rat d-serine racemase (NCBI accession number NM_198757)] do not opt for region near the start codon (within 50-100 bases), nor untranslated regions [9, 10] . See Note 4. 4. Examine the 19 bases oligonucleotide for secondary structure and long base runs, both of which can interfere with the process of annealing.
Sequences that have at
5. Filter out, by appropriate database search, candidate targets that are present in other genes to avoid silencing of these loci. See Note 6.
6. Add the 7-9 nt hairpin loop sequence between sense and antisense strand [11] [12] [13] [14] . One of the most effective loop sequences for H1 promoter is TTCAAGAGA [15] .
7. Place a stretch of 5-6 T at the end of ShRNA to guarantee the termination of RNA polymerase III transcription.
8. Add to the end of two complementary oligonucleotides restriction sites (in our case MLu I at 5′ and Cla I at 3′) (see Fig. 1 ).
9. Include a negative control ShRNA. Usually ShRNA design online tools returns a scrambled sequence with the same nucleotide composition as your siRNA/shRNA input sequence.
10. Sense and antisense oligos must be phosphorylated and PAGE purified in order to increase cloning efficiency. When ordering, be sure to require that oligonucleotides are supplied after PAGE purification.
For expedience, annealing can be done in a thermal cycler.
1. Resuspend each PAGE-purified oligonucleotide in TE buffer to a concentration of 100 μM.
2. Mix the oligos for the sense strand and the anti strand at a 1:1 ratio. This will ultimately give 50 μM of ds oligonucleotide (assuming 100 % theoretical annealing). 4. Heat at 72 °C for 2 min.
5. Heat at 37 °C for 2 min.
6. Heat at 25 °C for 2 min.
7. Store on ice or at −20 °C until use. 2. For each ligation, add the following reagents in a microfuge tube:
Annealing of shRNA Oligonucleotides
• • 2 μL digested (MLu I/Cla I) and dephosphorylated pLVTHM vector (100 ng/μL).
• • 4 μL diluted, annealed oligonucleotide (0.5 μM).
• • 2 μL 10× T4 DNA ligase buffer.
• • 0.5 μL BSA (10 mg/mL).
• • 11 μL Nuclease-free H 2 O.
• • 0.5 μL T4 DNA ligase (400 U/μL).
• • For a 20 μL total volume.
3. Set up separate ligation using 2 μL of the negative scramble control ShRNA annealed oligonucleotide.
4. Set up separate ligation using 2 μL of digested (MLu I/Cla I) pLVTHM vector (50 ng/μL) without annealed oligonucleotide. • • −10 μg of lentivector pLVTHM.
• • −3.5 μg of pMD2G (Gag-Pol).
• 9. Collect the supernatant from the plates and centrifuge at 500 × g for 10 min to remove cell debris and filter through 0.45 μm filters. See Note 15.
10. Add 15 mL of fresh medium to each plate and incubate overnight. Filtered supernatants can be stored for several days at 4 °C.
11. Collect media and filter as in step 9. See Note 16.
12. Pool collected supernatants from steps 9 and 11. Transfer to Beckman tubes using 25-29 mL per tube.
13. Concentrate viral particles by centrifuging in a Beckman SW 28 rotor at 65,000 × g or 2 h at 20 °C.
14. Resuspend all pellets in a total of 1 mL of HBSS and wash tubes a second time with 1 mL of HBSS.
15. Increase the combined volume from 2 to 3 mL with HBSS and layer the resuspended pellets on 1.5 mL of a 20 % sucrose (in HBSS) cushion in Beckman tubes.
16. Centrifuge using a Beckman SW 55 rotor at 53,500 × g for 1.5 h at 20 °C.
17. Resuspend the pellet in 100 μL of HBSS containing 1 % BSA and wash the tube with an additional 100 μL of HBSS containing 1 % BSA. Shake the resuspended viral preparation on a low-speed vortexer for 15-30 min. Centrifuge for 10 s to remove debris.
18. Aliquot the cleared viral solution and store at -80 °C. It can be stored for many months. Avoid repeated freeze-thaw cycles.
19. Titrate the viral preparations by biological titration using GFP, which is the marker contained in the lentivector. The fraction of GFP fluorescent cells can be counted by FACS (fluorescence activated cell sorting). GFP fluorescence may be also visualized under a fluorescence microscope. Usually 10-15 random fields of view are used to estimate the overall fraction of fluorescing cells in each well.
Cultures enriched in CGNs are obtained from dissociated cerebella of 8-day-old Wistar rats according to Levi et al. [16] . The preparation of CGN cultures is carried out at Day 1, transduction at Day 2, induction and detection of apoptosis at Days 6-7.
1. Remove 4-5 cerebella from 8-day-old rats and slice them (0.4 mm thickness) with a mechanical tissue chopper.
2. Suspend in 10 mL solution A, centrifuge for 15 s at 150 × g.
3.
Resuspend the tissue in 10 mL solution A containing 0.25 μg/ mL trypsin III and incubate at 37 °C for 15 min in a shaking water bath at rate of 125 rpm.
4. Add to the suspension 10 mL solution A containing 12.8 μg DNAase I and 83 μg soybean trypsin inhibitor.
5. Centrifuge immediately for 15 s at 150 × g.
6.
Resuspend the pellet in 2 mL of solution A containing 80 μg DNAase I, 0.52 mg soybean trypsin inhibitor and 2.7 mM MgSO 4 . Triturate the tissue with a Pasteur pipette (25 strokes).
7. Allow the suspension to stand for 15 min, aspirate carefully the upper 1.5 mL, readjust the volume to about 2 mL ad dissociate as above. After allowing the suspension to stand for 15 min, take off the supernatant, leaving only 0.2 mL containing clumps and debris.
8. Transfer the supernatant into 3 mL Solution A containing 0.1 mM CaCl 2 . After about 10 min decant the supernatant, allow to stand for another 10 min and resuspend the pellet in CGN culture medium.
9. Count the cell in the suspension.
10. Plate 4 × 10 5 CGN per well in a NUNC 24-well plate in 800 μL CGN culture medium. Incubate the cells at 37 °C with 5 % CO 2 .
11. After 24 h add 10 μM 1β-Arabinofuranosylcytosine to CGN culture medium to prevent proliferation of non-neuronal cells.
1. Transduce CGN cells with lentivirus. For each well, prepare 50 μL of virus suspension diluted in CGN culture medium (See Note 17). To transduce CGN reduce the volume of the
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Short hairpin RNAs medium to one-third; add the recombinant lentivirus at different dilutions. Allow the virus to adsorb for 1-2 h, thus render back the medium to its original volume. Then cultivate neurons up to 6-7 days in vitro (DIV) when apoptosis will be induced (Fig. 1) .
Induction of apoptosis is carried out in serum-free medium at low (5 mM) KCl [17] .
1. Wash cultures twice and maintain in serum-free low (5 mM) KCl CGN culture medium for 8 h.
2. Wash and maintain control cultures in serum-free CGN culture medium for 8 h.
Measure caspase 3 activity as follows:
1. Wash 500,000 CGNs with PBS once.
2. Add 100 μL of caspase 3 lysis buffer A to lyse cells.
3. Combine 25 L of lysate with 75 μL of caspase 3 assay buffer B containing 30 μM Ac-DEVD-AMC.
4. Incubate for 20 min at room temperature.
5. Measure fluorescence at an excitation of 380 nm and an emission of 460 nm using a spectrofluorometer (Fig. 2 ).
Induction and Detection of Apoptosis
Induction of Apoptosis
Detection of Apoptosis
Fig. 2
In vitro CGNs (2 DIV) were transducted either with Sh-RNA/scramble and Sh-RNA/SR lentivirus at MOI 40. At 6DIV they were induced to undergo apoptosis by serum and KCl deprivation (S-K5); control cells were maintained in serumfree medium supplemented with 25 mM KCl (S-K25). Eight hours after apoptosis induction neurons were lysed and assayed for DEVD-MCA cleavage. Foldinduction of caspase-3 activity is the mean (±SEM) of triplicate determinations from three independent experiments. Note that silencing of SR increases caspase-3 activity in CGNs undergoing apoptosis, suggesting that this enzyme has a protective role in survival of CGN (see ref. 17) 1. Extract total proteins by scraping cells in SDS-reducing sample buffer.
2. Boil for 5 min.
3. Perform western blot analysis with mouse anti-d-serine racemase antibody (see Fig. 3a ).
1. Fix and permeabilize CGN cultured in the chamber slide with methanol 100 % for 20 min at −20 °C.
2. Block with 4 % NGS in PBS for 1 h at room temperature. 6. Wash three times with PBS.
7. Remove excess moisture from the slide before adding anti-fade mounting medium.
8. Examine slide under fluorescence/confocal microscope (see Fig. 3b ). 4. Although it is recommended to avoid to select target sequence in the untranslated regions, since regulatory protein binding to regions in and near the untranslated region might interfere with the RNAi process, in some case targets within the untranslated regions (UTR) have been also reported [18] .
Notes
5. Avoid selecting target sense or antisense sequences that contain a consecutive run of three or more thymidine residues; a poly(T) tract within the sequence can potentially cause premature termination of the shRNA transcript.
6. Many online tools to design shRNA gives a link to the NCBI BLAST server to search for similarity of the suggested target against the mRNA database of the organism of interest.
7. Heating to 95 °C is essential to remove all secondary structure, disrupt the internal hairpin of each oligonucleotide and promote intermolecular annealing. 
